The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and represent the first new class of pain medications in 20 years—and the first non ...

U.S. needs to pursue evidence-based interventions for substance use disorders. It’s unclear to what degree the Trump ...

Insider activity is seldom enough to move a market independently but can signal how a company’s management thinks. Exclusive content, detailed data sets, and best-in-class trade insights to ...

The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.

The FDA has approved a new type of painkiller that doesn't come with the risks of addiction and overdose associated with opioids.